Co-host Kathy Miller, M.D., will discuss the significance of last week’s FDA approval of the cancer drug Avastin for treatment of metastatic breast cancer. Avastin previously was FDA-approved for the treatment of colorectal and lung cancer but has met opposition for approval for breast cancer treatment.
Co-host Ora Pescovitz, M.D., will speak with David Stocum, Ph.D., director of the Center for Regenerative Biology at Indiana University-Purdue University at Indianapolis, about his work with salamanders and their ability to regenerate limbs. Dr. Stocum’s research seeks insights into human limb re-growth.
Steve Bodgewic, Ph.D., associate chair of family medicine at Indiana University School of Medicine, will talk with Christoph Westphal, M.D., Ph.D., CEO of Sirtris Pharmaceuticals, about one of the company’s drugs that counters the effects of aging. In trials, the drug has been shown to reduce the symptoms of several age-related diseases including diabetes.
Sound Ethics with Eric M. Meslin, Ph.D., director of the IU Center for Bioethics, and Andrew Vickers, Ph.D., a biostatistician at Memorial Sloan Kettering Cancer Center, will discuss Vickers’ New York Times essay questioning the refusal of some researchers to share their raw data, even after the results have been published. As a biostatistician, Dr. Vickers relies on such data to help design studies and interpret results.